WELCOME TO THE PERSONAL WEB PAGE OF
Dr. Andreas Scorilas, Ph.D
Professor of Clinical Biochemistry,
Department of Biochemistry & Molecular Biology, Faculty of Biology
National and Kapodistrian University of Athens, Greece.
• 430 publications in international peer review scientific journals, including publications in top class journals such as Clinical Chemistry, Journal of Clinical Oncology, Nature Medicine, Cancer Research, Clinical Cancer Research etc.
• Total Impact Factor, I.F>2.200 (5 / publication)
• >22.000 citations
• h-Index > 80
• 8 Patents
• 7 Books and 16 Book Chapters
• >350 publications in proceedings of international conferences.
• >1500 original complete gene entries in GeneBank of NCBI, 6 gene cards
• 120 publications in Greek
• Coordinator in >20 accomplished national and international research grants
* Discovery and validation of novel molecular tumor biomarkers
* Development of ultra-sensitive molecular methodologies and Omics technologies
* Molecular diagnostics
* Next and third generation sequencing
* Non coding RNAs (ncRNAs)
* Cancer pharmacogenomics and therapeutics
* Mechanisms of carcinogenesis and cancer progression
Overview of Research Activities
Graduate courses
Pathobiochemistry (Coordinator)
Molecular Diagnostics (Coordinator)
Molecular bases off human diseases
Molecular biology - molecular diagnostic techniques
Biostatistics - Bioinformatics
Laboratory management
Undergraduate courses
Clinical Biochemistry (Coordinator)
Topics in Contemporary Molecular Biology (Coordinator)
Topics in Contemporary Molecular Biology (Coordinator)
* Discovery, cloning and identification of the following novel cancer-related genes:
- The novel apoptotic BCL2L12 gene
- The new carcinoembryonic antigen gene CEAL1 (CEACAM19)
- The SR-A1 gene (SCAF1)
- TSKS, AP2A1 etc
* Characterization and study of the kallikrein gene family members KLK7, KLK11, KLK15
* Elucidation of the clinical significance of kallikrein genes and other cancer-related genes,
in several human malignancies.
* Development of novel bioanalytical methodologies, useful in Biochemistry and Molecular Diagnostics.
* Clarification of the clinical value of kallikrein family genes and other cancer-related genes in various neoplasms.
* Development of a novel ultra-sensitive and reliable molecular methodology for the quantitative determination
of small non-coding RNA molecules (miRNA) - internationally established today.
* Development of a new ultra-sensitive and reliable molecular methodology for the detection of mutant strains
of SARS-CoV-2 in environmental and wastewater samples - internationally established today.
